Characteristics of Diabetic Foot Ulcer Patients

Examining the Demographic, Clinical, and Laboratory Data of Patients With Diabetic Foot Ulcers Admitted to 5 Azar Hospital in 2024 (Registry Project)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07188337

Enrollment

200

Registered

2025-09-23

Start date

2025-07-27

Completion date

2025-11-30

Last updated

2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Complications, Diabetic Foot Ulcer

Keywords

diabetic foot ulcer, diabetes mellitus, amputation, neuropathy

Brief summary

This study examines the demographic, clinical, and laboratory characteristics of patients with diabetic foot ulcers admitted to 5 Azar Hospital, Gorgan, in 2024. By analyzing factors such as Hb, WBC, HbA1C, ESR, and CRP in relation to ulcer severity, the study aims to identify predictors of outcomes and support more effective prevention and management strategies

Detailed description

Diabetic foot ulcer (DFU) is one of the most serious and preventable complications in diabetic patients, often leading to infection, hospitalization, lower limb amputation, and increased mortality. This cross-sectional descriptive-analytical study aims to investigate the demographic, clinical, and laboratory characteristics of approximately 200 patients with DFU admitted to 5 Azar Hospital, Gorgan, in 2024. Data will be retrospectively collected from medical records after obtaining ethical approval. The study will analyze relationships between patient demographics, clinical features, and laboratory findings (including Hb, WBC, HbA1C, ESR, CRP) with ulcer severity based on Wagner's classification. Statistical tests such as independent t-test, chi-square, Fisher's exact test, and multivariable logistic regression will be used. By identifying key factors associated with ulcer severity and outcomes, the findings of this study may contribute to more effective prevention and management strategies for diabetic foot ulcers, ultimately reducing complications and healthcare costs

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Patients admitted to 5 Azar Hospital, Gorgan, in 2024 * Diagnosis of diabetic foot ulcer (DFU) confirmed by medical records * Complete demographic, clinical, and laboratory data available in medical files

Exclusion criteria

* Incomplete or missing medical records * Patients with foot ulcers of non-diabetic etiology * Patients whose key laboratory data are unavailable

Design outcomes

Primary

Measure	Time frame	Description
Severity of diabetic foot ulcer (measured by Wagner classification at admission)	Baseline	Measured by Wagner classification
Laboratory parameters and ulcer grade	Baseline	Association between Hb, WBC, HbA1C, ESR, and CRP levels with Wagner ulcer grade

Secondary

Measure	Time frame	Description
Treatment outcomes	At hospital discharge (average of 10 days)	Frequency of outcomes: antibiotic therapy, wound debridement, or amputation
Duration of diabetes until ulcer onset	Baseline	Time (in years) between diabetes diagnosis and first DFU occurrence
Demographic distribution	Baseline	Age, sex, occupation, and ethnicity of DFU patients
Ulcer recurrence	During 12-month follow-up (based on records)	Number of hospital readmissions due to DFU.
Smoking status and ulcer severity	Baseline	Correlation between smoking history (yes/no) and Wagner ulcer grade

Countries

Iran

Contacts

Primary ContactPezhman Kharazm

pezhmankh@goums.ac.ir09111751861

Outcome results